Suchergebnisse - "Poorbaugh, Josh"

PubPharm (22)

1

Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL-17A (LY3509754) : A Phase I Randomized Placebo-Controlled Study

enthalten in: Clinical pharmacology and therapeutics | 2024

von Datta-Mannan, A. | Regev, A. | Coutant, D. | +7

2

Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A( LY3509754) : A Phase I Randomized Placebo‐Controlled Study

enthalten in: Clinical Pharmacology & Therapeutics | 2024

von Datta‐Mannan, A. | Regev, A. | Coutant, D. | +7

3

Evaluation of plasma IL-21 as a potential biomarker for type 1 diabetes progression

enthalten in: Frontiers in immunology | 2023

von Schroderus, A. | Poorbaugh, J. | McElyea, S. | +11

4

Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients

enthalten in: Journal of translational medicine | 2022

von Sims, J. | Chang, C. | Poorbaugh, J. | +13

5

Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients

enthalten in: Journal of translational medicine | 2022

von Sims, J. | Chang, C. | Poorbaugh, J. | +13

6

Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients

enthalten in: Journal of translational medicine | 2022

von Sims, J. | Chang, C. | Poorbaugh, J. | +13

7

The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination

enthalten in: Science translational medicine | 2022

von Benschop, R. | Tuttle, J. | Zhang, L. | +13

8

Level and Duration of IgG and Neutralizing Antibodies to SARS-CoV-2 in Children with Symptomatic or Asymptomatic SARS-CoV-2 Infection

enthalten in: ImmunoHorizons | 2022

von Khaitan, A. | Datta, D. | Bond, C. | +8

9

Level and duration of IgG and neutralizing antibodies to SARS-CoV-2 in children with symptomatic or asymptomatic SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2022

von Khaitan, A. | Datta, D. | Bond, C. | +7

10

Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab

enthalten in: Journal of translational medicine | 2022

von Sims, J. | Poorbaugh, J. | Chang, C. | +9